MENU
+Compare
IVRO
Stock ticker: OTC
AS OF
Nov 18 closing price
Price
$0.09
Change
-$0.01 (-10.00%)
Capitalization
2.09M

IVRO InVitro International Forecast, Technical & Fundamental Analysis

Invitro International is a provider of non-animal testing methods... Show more

IVRO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IVRO with price predictions
Nov 18, 2025

IVRO in upward trend: 10-day moving average crossed above 50-day moving average on October 14, 2025

The 10-day moving average for IVRO crossed bullishly above the 50-day moving average on October 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where IVRO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IVRO just turned positive on November 17, 2025. Looking at past instances where IVRO's MACD turned positive, the stock continued to rise in of 58 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IVRO advanced for three days, in of 34 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 120 cases where IVRO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IVRO moved out of overbought territory on November 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (11.917). P/E Ratio (0.000) is within average values for comparable stocks, (129.232). IVRO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.872). IVRO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.000) is also within normal values, averaging (9.613).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
IVRO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
330 East Orangethorpe Avenue
Phone
+1 949 851-8356
Employees
7
Web
https://www.invitrointl.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKE18.080.30
+1.69%
Skeena Resources Limited
BNT43.330.59
+1.38%
Brookfield Wealth Solutions Ltd
DLHC5.820.02
+0.26%
DLH Holdings Corp
NUS9.530.02
+0.21%
NuSkin Enterprises
SUNE1.23-0.03
-2.38%
SUNation Energy Inc

IVRO and Stocks

Correlation & Price change

A.I.dvisor tells us that IVRO and ECIA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVRO and ECIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVRO
1D Price
Change %
IVRO100%
-7.91%
ECIA - IVRO
20%
Poorly correlated
+4.71%
NMTC - IVRO
20%
Poorly correlated
-5.48%
IOBCF - IVRO
13%
Poorly correlated
N/A
KLYG - IVRO
9%
Poorly correlated
-26.53%
GCTK - IVRO
8%
Poorly correlated
-3.10%
More